Nycomed Amersham rationalises manufacturing
This article was originally published in Clinica
Executive Summary
Nycomed Amersham has sold its US factory which makes the chemicals used in its X-ray contrast imaging agents to the management team. The Rensselaer facility near Albany, New York, is the subject of a $59 million management buyout which is scheduled to be completed by the end of the year. The new company will be called Organichem.